Shots:
CSPC has granted Radiance exclusive rights to develop & market RB-164 in the US, Canada, EU, UK, Switzerland, Norway, Iceland, Liechtenstein, Albania, Montenegro, North Macedonia, Serbia, & Australia, while retaining rights to other markets
As per the deal, CSPC will get $15M upfront, ~$150M in development & regulatory milestones and ~$1B in commercial…
